S. Moudourou

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

V. Colizzi, C. Perno, S. Billong, 2020, Antimicrobial Resistance & Infection Control.

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”

V. Colizzi, C. Perno, S. Billong, 2019, AIDS Research and Therapy.

Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon

L. Kaptue, J. Ateudjieu, D. Mbanya, 2010, International journal of environmental research and public health.

Hemophilia in Developing Countries: An Analysis of the First Data in Cameroon, Africa

D. Mbanya, C. Tagny, S. Moudourou, 2014 .

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

F. Ceccherini‐Silberstein, C. Perno, V. Colizzi, 2021, HIV medicine.

Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon

M. Andreoni, V. Colizzi, J. Torimiro, 2012, Journal of medical virology.

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy

J. Torimiro, A. Nanfack, K. Njefi, 2018, BMC Pregnancy and Childbirth.

[Concentrated red blood cells transfusion in Yaoundé, Cameroon: what quality?].

J. Ngogang, C. Tayou Tagny, B. Nouthe, 2007, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy.

L. Bonnett, A. Geretti, C. Kouanfack, 2019, The Journal of antimicrobial chemotherapy.

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

V. Colizzi, C. Perno, S. Billong, 2023, Medicine.